Novel 4-Thiazolidinone Derivatives as Anti-Infective Agents: Synthesis, Characterization, and Antimicrobial Evaluation

Table 3

Values of the minimum inhibitory concentration of the synthesized compounds and reference standards.

S. number	Microbial strains	MIC of compounds (µg/mL)
		4a	4b	4c	4d	4e	4f	N	F
1	Staphylococcus aureus	300	500	300	400	400	300	2.5	—
2	Bacillus subtilis	300	200	400	300	300	100	5	—
3	Bacillus pumilus	300	100	300	100	200	500	1.25	—
4	Micrococcus luteus	300	500	500	300	300	300	—	—
5	Pseudomonas aeruginosa	200	300	300	300	400	400	2.5	—
6	Pseudomonas fluorescens	100	100	300	100	200	300	2.5	—
7	Escherichia coli	300	100	300	400	400	200	2.5	—
8	Aspergillus niger	300	100	100	100	300	300	—	2.5
9	Penicillium chrysogenum	400	100	100	100	300	300	—	1.25

N: norfloxacin and F: fluconazole.